Skip to main content
. 2012 Nov 14;2012(11):CD008079. doi: 10.1002/14651858.CD008079.pub2

Analysis 2.6.

Analysis 2.6

Comparison 2 Anti‐leukaemic therapy with anti‐CD20 antibody versus anti‐leukaemic therapy without anti‐CD20 antibody (anti‐leukaemic therapy not identical in both groups), Outcome 6 Treatment‐ related mortality ‐ subgrouped by different anti‐CD20 antibody treatment regimens.